Orphan Drug and Vaccine Development for Rare Diseases

Global laboratory solutions for orphan drug and vaccine development

Drug developers for rare diseases require a partner that understands the unique, complex needs of orphan drug development. Q2 Solutions’ industry-leading scientists partner with you to optimize your study design and accelerate regulatory approval.

With global end-to-end laboratory solutions, we offer assay development services, immunogenicity testing, genomic solutions, efficacy monitoring, project management and data management to meet your orphan drug and vaccine development needs.

Learn more about our orphan drug and vaccine development capabilities for rare diseases:
Zika Vaccine Research: Complex Steps Toward a Critical Need

Overcoming Zika vaccine development challenges

Q2 Solutions Anti-infective and Vaccine Development Services

Assays to drive success in anti-infective and vaccine development

Extensive expertise for vaccine assay development and diagnostics

Delivery Excellence for Anti-infective and Vaccine Development

Supply chain and quality management systems to ensure sample integrity for high-quality data delivery

Read More